1 year return (CAGR)
52.38%
iBio, Inc. Common Stock Exchange (NASDAQ, USD)
IBIO
1.28
+0.03 (+2.40%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-45.71%
5 year return (CAGR)
-70.62%
10 year return (CAGR)
-53.97%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
63.59M
Price/Sales
635.89
Ent value
20.59M
Price/Book
0.74
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-64.87%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.28 |
| Daily high | 1.30 |
| Daily low | 1.24 |
| Daily Volume | 421K |
| All-time high | 29250.00 |
| 1y analyst estimate | 5.53 |
| Beta | 1.29 |
| EPS (TTM) | -0.32 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IBIO | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.38% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 12 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -86.86% | -10.68% |
| Avg time to new high | 134 days | 12 days |
| Max time to new high | 3941 days | 1805 days |
News
